Multi-omics analysis reveals drivers of loss of β-cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter study

AIMS: Heterogeneity in the rate of β-cell loss in newly diagnosed type 1 diabetes patients is poorly understood and creates a barrier to designing and interpreting disease-modifying clinical trials. Integrative analyses of baseline multi-omics data obtained after the diagnosis of type 1 diabetes may...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	DIABETES-METABOLISM RESEARCH AND REVIEWS 2024-07, Vol.40 (5)
Hauptverfasser:	Armenteros, Jose Juan Almagro, Brorsson, Caroline, Johansen, Christian Holm, Banasik, Karina, Mazzoni, Gianluca, Moulder, Robert, Hirvonen, Karoliina, Suomi, Tomi, Rasool, Omid, Bruggraber, Sylvaine F.A, Marcovecchio, M. Loredana, Hendricks, Emile, Al-Sari, Naba, Mattila, Ismo, Legido-Quigley, Cristina, Suvitaival, Tommi, Chmura, Piotr J, Knip, Mikael, Schulte, Anke M, Lee, Jeong Heon, Sebastiani, Guido, Grieco, Giuseppina Emanuela, Elo, Laura L, Kaur, Simranjeet, Pociot, Flemming, Dotta, Francesco, Tree, Tim, Lahesmaa, Riitta, Overbergh, Lut, Mathieu, Chantal, Peakman, Mark, Brunak, Soren
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!